サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1515545

バイオシミュレーション市場：製品別、用途別、デリバリーモデル別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Biosimulation Market, By Product, By Application, By Delivery Model, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 299 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオシミュレーション市場：製品別、用途別、デリバリーモデル別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バイオシミュレーション市場規模は2023年に31億2,520万米ドルとなり、2024年から2032年にかけてCAGR 17.2％で拡大

バイオシミュレーション市場- 市場力学

医薬品開発コストの削減

バイオシミュレーションの利用による医薬品開発コストの削減は、世界のバイオシミュレーション市場を牽引する主要因です。バイオシミュレーションにより、製薬企業は、コストと時間のかかる動物実験や臨床試験を実施する前に、コンピュータシミュレーションを用いて潜在的な医薬品候補を試験することで、医薬品開発における財務リスクを低減することができます。このインシリコ、すなわちコンピュータベースのモデリングとシミュレーションにより、研究者は何百万ものwhat-ifシナリオをテストし、実際の個人を利用することなく、人体内で望ましい反応が起こるように薬剤分子を最適化することができます。バイオシミュレーションの利用によるコストと時間の節約は大きいです。米国食品医薬品局（FDA）によると、前臨床研究を開始した医薬品候補のうち、ヒト試験に進むのはわずか1万件に1件であり、開発中の減少率が大きいことが示されています。同様に、タフト医薬品開発研究センター（Tuft Center for the Study of Medicine Development）は、新薬の上市にかかる平均コストを26億米ドルと見積もっています。バイオシミュレーションによって達成されるコストと時間の節約は、ほんのわずかであっても莫大な節約に相当します。

バイオシミュレーション市場-主要洞察

当社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約17.2%のCAGRで毎年成長すると推定されます。

製品セグメンテーションに基づくと、ソフトウェア分野が2023年の市場を独占しました。

用途セグメンテーションに基づくと、予測期間中にCAGRが最も大きくなると予測されるのは創薬です。

デリバリーモデルのセグメンテーションに基づくと、2023年には製薬会社、バイオテクノロジー会社が主要なタイプでした。

地域別では、北米が2023年に収益でリードしました。

バイオシミュレーション市場-セグメンテーション分析：

世界のバイオシミュレーション市場は、製品、用途、デリバリーモデル、最終用途、地域に基づいて区分されます。

製品は2つに分類される：ソフトウェアとサービスです。2023年にはソフトウェアカテゴリーが市場を独占します。これは、独自の研究開発ニーズに対応するための用途特化型ソフトウェアが市場に豊富に存在するためです。

市場は用途別に3つのカテゴリーに分類される：医薬品開発、創薬、その他です。予測期間中、CAGRが最も高くなると予想されるのは創薬です。薬理ゲノミクスや薬理遺伝学などの分野でバイオシミュレーションの利用が拡大していることが、同分野の成長を後押ししています。Certaraは、2020年2月にSilico Biosciences, Inc.の神経変性疾患研究用に設計されたモデリングおよびシミュレーション技術プラットフォームを買収しました。これは、同社の神経変性疾患研究における定量的システム薬理学（QSP）ビジネスモデルに利益をもたらしました。

バイオシミュレーション市場-地理的洞察

バイオシミュレーション市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は2023年に最も高い収益シェアを占めました。重要なアクターの存在、ヘルスケアのデジタル化の進展、慢性的な健康不安の有病率の上昇がすべてこの拡大に寄与しています。さらに、患者の高い安全性と治療基準を確保するための規制政策の実施におけるインシリコモデルの利用が、この地域の市場成長を後押ししています。

アジア太平洋地域は、公共部門と民間部門の活動が活発化し、ヘルスケア・インフラが一貫して整備された結果、予測期間を通じて飛躍的な成長が見込まれています。さらに、新興国の研究開発努力の拡大は、この地域に大きな経済的可能性をもたらすと期待されています。

バイオシミュレーション市場：競合情勢：

バイオシミュレーション市場の競合情勢では、複数の重要な競合企業が市場の覇権を争っています。米国Certara社、Dassault Systemes社、Advanced Chemistry Development社、Simulation Plus社、Schrodinger, Inc.社などは、この市場の主要企業です。これらの企業は、高度なバイオシミュレーションソフトウェア、モデリング能力、薬物動態学および薬力学シミュレーションの経験でよく知られています。バイオシミュレーション市場の競争を促進する競合要因には、ソフトウェアの性能、予測精度、規制対応、カスタマイズ医療や医薬品開発に対するニーズの高まりへの対応力などがあります。バイオシミュレーション市場の競合情勢は、継続的な研究開発、戦略的提携、技術革新の重視によって形成されています。

目次

第1章 バイオシミュレーション市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオシミュレーションの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオシミュレーション産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオシミュレーション市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオシミュレーション市場情勢

  • バイオシミュレーション市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオシミュレーション市場- 製品別

  • 概要
    • セグメントシェア分析
    • ソフトウェア
    • サービス

第8章 バイオシミュレーション市場- 用途別

  • 概要
    • セグメントシェア分析
    • 医薬品開発
    • 創薬
    • その他

第9章 バイオシミュレーション市場- デリバリーモデル別

  • 概要
    • セグメントシェア分析
    • サブスクリプションモデル
    • 所有モデル

第10章 バイオシミュレーション市場- 最終用途別

  • 概要
    • セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • CRO
    • 規制当局
    • 学術研究機関

第11章 バイオシミュレーション市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- バイオシミュレーション業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Certara, USA
    • Dassault Systemes
    • Advanced Chemistry Development
    • Simulation Plus
    • Schrodinger, Inc.
    • Chemical Computing Group ULC
    • Physiomics Plc
    • Rosa &Co. LLC
    • BioSimulation Consulting Inc.
    • Genedata AG
    • Instem Group of Companies
    • PPD, Inc.
    • Yokogawa Insilico Biotechnology GmbH
    • Immunetrics
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biosimulation Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Biosimulation Market, by Product 2019-2032 (USD Million)
  • TABLE Biosimulation Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biosimulation Market, by Application 2019-2032 (USD Million)
  • TABLE Biosimulation Market: Delivery Model Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Delivery Model
  • TABLE Global Biosimulation Market, by Delivery Model 2019-2032 (USD Million)
  • TABLE Biosimulation Market: End-use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Biosimulation Market, by End-use 2019-2032 (USD Million)
  • TABLE Biosimulation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biosimulation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Biosimulation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Biosimulation Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Biosimulation Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Biosimulation Market, by Delivery Model, 2019-2032 (USD Million)
  • TABLE North America Biosimulation Market, by End-use, 2019-2032 (USD Million)
  • TABLE Europe Biosimulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Biosimulation Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Biosimulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Biosimulation Market, by Delivery Model, 2019-2032 (USD Million)
  • TABLE Europe Biosimulation Market, by End-use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biosimulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biosimulation Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biosimulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biosimulation Market, by Delivery Model, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biosimulation Market, by End-use, 2019-2032 (USD Million)
  • TABLE Latin America Biosimulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Biosimulation Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Biosimulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Biosimulation Market, by Delivery Model, 2019-2032 (USD Million)
  • TABLE Latin America Biosimulation Market, by End-use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biosimulation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biosimulation Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biosimulation Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biosimulation Market, by Delivery Model, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biosimulation Market, by End-use, 2019-2032 (USD Million)

List of Figures

  • FIGURE Biosimulation Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Delivery Model segment market share analysis, 2023 & 2032
  • FIGURE Delivery Model segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-use segment market share analysis, 2023 & 2032
  • FIGURE End-use segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Biosimulation Market share and leading players, 2023
  • FIGURE Europe Biosimulation Market share and leading players, 2023
  • FIGURE Asia Pacific Biosimulation Market share and leading players, 2023
  • FIGURE Latin America Biosimulation Market share and leading players, 2023
  • FIGURE Middle East and Africa Biosimulation Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Biosimulation Market share analysis by country, 2023
  • FIGURE Germany Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Biosimulation Market share analysis by country, 2023
  • FIGURE India Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Biosimulation Market share analysis by country, 2023
  • FIGURE Brazil Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Biosimulation Market share analysis by country, 2023
  • FIGURE Saudi Arabia Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Biosimulation Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3307

REPORT HIGHLIGHT

Biosimulation Market size was valued at USD 3,125.2 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

Biosimulation is a mathematical simulation of a biological procedure that uses computer programs to model biological processes and systems. Model-based drug development refers to the ability to make data-driven decisions utilizing a quantitative framework throughout the drug development process. Biosimulation is a promising technology used in pharmaceutical research to improve the drug discovery and development process.

Biosimulation Market- Market Dynamics

Reduced Drug Development Costs

The reduction in drug development costs achieved through the use of biosimulation is a major factor driving the global biosimulation market. Biosimulation allows pharmaceutical companies to reduce financial risks in drug development by testing potential drug candidates using computer simulation before going on to costly and time-consuming animal and clinical studies. This in silico, or computer-based, modeling and simulation enables researchers to test millions of what-if scenarios to optimize drug molecules for desired reactions in the human body without utilizing real individuals. The cost and time savings from using biosimulation are significant. According to the United States Food and medication Administration (FDA), just one in every 10,000 medication candidates that begin preclinical research progresses to human testing, indicating a significant attrition rate during development. Similarly, the Tuft Center for the Study of Medicine Development estimates that the average cost of bringing a new medicine to market is $2.6 billion. Even a modest fraction of cost and time savings achieved through biosimulation equates to huge savings.

Biosimulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Product segmentation, The software sector dominated the market in 2023.

Based on application segmentation, Drug discovery is predicted to have the greatest CAGR during the projection period.

Based on Delivery Model segmentation, Pharmaceutical, and biotechnology companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biosimulation Market- Segmentation Analysis:

The Global Biosimulation Market is segmented based on Product, Application, Delivery Model, End-use, and Region.

The market is divided into two categories based on Product: Software and Services. The software category dominated the market in 2023. This is due to the abundance of application-specific software available in the market to meet unique research and development needs.

The market is divided into three categories based on application: Drug Development, Drug Discovery, and Others. Drug discovery is expected to have the highest CAGR over the projection period. The expanding use of biosimulation in fields such as pharmacogenomics and pharmacogenetics is helping to drive the segment's growth. Certara purchased Silico Biosciences, Inc.'s modeling and simulation technology platform designed for the research of neurodegenerative disorders in February 2020. This benefited the company's quantitative systems pharmacology (QSP) business model in its research into neurodegenerative illnesses.

Biosimulation Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America had the highest revenue share in 2023. The existence of important actors, increased healthcare digitization, and the rising prevalence of chronic health concerns all contribute to this expansion. Furthermore, the use of in-silico models in the implementation of regulatory policies to ensure high patient safety and treatment standards is helping to drive regional market growth.

The Asia Pacific region is expected to grow at an exponential rate throughout the projection period as a result of increased public and private sector activities and consistent upgrades to healthcare infrastructure. Furthermore, emerging economies' expanding R&D efforts are expected to provide major economic possibilities for the region.

Biosimulation Market- Competitive Landscape:

In the competitive landscape of the Biosimulation Market, several significant competitors compete for market domination. Certara, USA, Dassault Systemes, Advanced Chemistry Development, Simulation Plus, and Schrodinger, Inc. are some of the market segment's leading companies. These firms are well-known for their advanced biosimulation software, modeling capabilities, and experience with pharmacokinetics and pharmacodynamics simulation. Factors driving competition in the Biosimulation Market include software performance, prediction accuracy, regulatory compliance, and the ability to meet the growing need for customized medicine and drug development. The Biosimulation Market's competitive landscape is shaped by ongoing R&D, strategic collaborations, and an emphasis on technological innovation.

Recent Developments:

In January 2022, Simulation Plus collaborated with a pharmaceutical business to improve the GastroPlus Advanced Compartmental Absorption and Transit (ACAT) model in support of ongoing research programs for gastrointestinal illnesses.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOSIMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Certara, USA

Dassault Systemes

Advanced Chemistry Development

Simulation Plus

Schrodinger, Inc.

Chemical Computing Group ULC

Physiomics Plc

Rosa & Co. LLC

BioSimulation Consulting Inc.

Genedata AG

Instem Group of Companies

PPD, Inc.

Yokogawa Insilico Biotechnology GmbH

Immunetrics

Others

GLOBAL BIOSIMULATION MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL BIOSIMULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Development
  • Drug Discovery
  • Others

GLOBAL BIOSIMULATION MARKET, BY DELIVERY MODEL- MARKET ANALYSIS, 2019 - 2032

  • Subscription Models
  • Ownership Models

GLOBAL BIOSIMULATION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

GLOBAL BIOSIMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biosimulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biosimulation Market Snippet by Product
    • 2.1.2. Biosimulation Market Snippet by Application
    • 2.1.3. Biosimulation Market Snippet by Delivery Model
    • 2.1.4. Biosimulation Market Snippet by End-use
    • 2.1.5. Biosimulation Market Snippet by Country
    • 2.1.6. Biosimulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Biosimulation Key Market Trends

  • 3.1. Biosimulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biosimulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biosimulation Market Opportunities
  • 3.4. Biosimulation Market Future Trends

4. Biosimulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biosimulation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biosimulation Market Landscape

  • 6.1. Biosimulation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biosimulation Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. Biosimulation Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Drug Development
    • 8.1.3. Drug Discovery
    • 8.1.4. Others

9. Biosimulation Market - By Delivery Model

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Model, 2023 & 2032 (%)
    • 9.1.2. Subscription Models
    • 9.1.3. Ownership Models

10. Biosimulation Market - By End-use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. CROs
    • 10.1.4. Regulatory Authorities
    • 10.1.5. Academic Research Institutions

11. Biosimulation Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biosimulation Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biosimulation Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biosimulation Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Biosimulation Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Biosimulation Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Model, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Biosimulation Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Certara, USA
    • 12.2.2. Dassault Systemes
    • 12.2.3. Advanced Chemistry Development
    • 12.2.4. Simulation Plus
    • 12.2.5. Schrodinger, Inc.
    • 12.2.6. Chemical Computing Group ULC
    • 12.2.7. Physiomics Plc
    • 12.2.8. Rosa & Co. LLC
    • 12.2.9. BioSimulation Consulting Inc.
    • 12.2.10. Genedata AG
    • 12.2.11. Instem Group of Companies
    • 12.2.12. PPD, Inc.
    • 12.2.13. Yokogawa Insilico Biotechnology GmbH
    • 12.2.14. Immunetrics
    • 12.2.15. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us